Inspire Medical Systems price to free cash flow INSP

Market value divided by free cash flow over the last twelve months, since 2023.

Today, Oct 23, 2026: 17.6×
3-year median: 31.6×
Against its 3-year history: 19th; percentile: 0 is its lowest day, 100 its highest
3-year range: 11.9× to 458×
Peer median: 28.1×

Inspire Medical Systems' price to free cash flow is 17.6× as of Oct 23, 2026.

That is below its 3-year median of 31.6×, lower than on 81% of days in the last 3 years.

Over that time it ranged from 11.9× in May 2026 to 458× in Nov 2023.

The median for 10 medical instruments and supplies stocks of a similar size is 28.1×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	17.6×	11.9×	28.9×
2025	28.1×	24.0×	159×
2024	148×	135×	154×
2023	458×	233×	458×

Against its peers

Companies in Medical - Instruments & Supplies nearest Inspire Medical Systems' size, closest first, today.

Company	Price to free cash flow
INSPInspire Medical Systems	17.6×
LMATLemaitre Vascular	26.2×
UFPTUFP Technologies	n/m
EYENational Vision	30.1×
ATRCAtriCure	56.5×
WRBYWarby Parker	147×
CDRECadre	16.4×
BVSBioventus	13.3×
STAAStaar Surgical	n/m
NVSTEnvista	15.3×
IRMDIradimed	43.7×
Peer median	28.1×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Inspire Medical Systems

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.